Calutide (Bicalutamide) – 50 Mg

✅ Key Benefits

• Blocks androgen receptors, limiting cancer cell proliferation

• Oral once-daily dosing simplifies treatment regimen

• Effective in advanced stages and metastatic prostate cancer

• Favorable side-effect profile compared to steroidal anti-androgens

🎯 How to Use

• Usually taken as one 50 mg tablet daily, with or without food

• Should be used in conjunction with LHRH agonists, unless monotherapy is advised

• Swallow with water; do not chew

• Continue therapy as prescribed by the oncologist

• Regular follow-up visits needed for monitoring

⚠️ Precautions

• Prescription‑only; requires specialist supervision

• Hepatic monitoring recommended—check liver enzymes periodically

• May cause elevated liver function tests, gastrointestinal upset, or gynecomastia

• Use with caution in patients with heart disease or risk factors

• Not suitable for women or children; pregnancy category X

🤕 Possible Side Effects

• Common: Hot flashes, breast tenderness, mild fatigue

• Hormonal effects: Gynecomastia, reduced libido, erectile dysfunction

• Gastrointestinal: Nausea, constipation, diarrhea

• Laboratory changes: Elevated liver enzymes, rare hepatotoxicity

• Serious (rare): Severe liver injury, lung toxicity—seek medical attention if symptoms occur

❓ Frequently Asked Questions (FAQs)

Q. Who should take Calutide?
A. Men with locally advanced or metastatic prostate cancer, often combined with LHRH agonists; occasionally as monotherapy in specific cases.

Q. Can Calutide be used alone?
A. Yes, in selected patients who cannot use LHRH therapy, though combination therapy is standard.

Q. How is liver health monitored?
A. Periodic liver function tests (ALT, AST, bilirubin) are recommended before starting and during treatment.

Q. What if a dose is missed?
A. Take as soon as remembered unless it’s near the next scheduled dose; do not double up.